CAPA along with 20 other health charities, patient organizations, and research networks, and led by Clinical Trials Ontario, submitted this input to Health Canada on its consultation paper related to its Regulatory Modernization Initiative. Health Canada is proposing to modernize the regulatory framework for clinical trials related to human drugs, medical devices, non-prescription drugs, and natural health products as part of the Health and Biosciences Sector Regulatory Review Roadmap. We felt that this was an important opportunity to provide input based on our community’s perspective especially related to patient engagement with Health Canada and within the clinical trials environment in Canada, transparency of clinical trial results, and ways for Canadians to find clinical trials if they are interested in participating in a clinical trial, to name a few areas. Please follow this link to view the submission.